Amylin Pharmaceuticals Inc., of San Diego, named Mark Foletta vice president of finance and chief financial officer.

ArQule Inc., of Woburn, Mass., named to its board of directors Tuan Ha-Ngoc, founder and CEO of eHealthDirect Inc., and Laura Avakian, vice president for human resources at the Massachusetts Institute of Technology.

Aurora Biosciences Corp., of San Diego, named Stuart Collinson president, CEO and chairman of the board of directors. In addition, John Pashkowsky was promoted to vice president, finance.

Cepheid, of Sunnyvale, Calif., elected to its board of directors Hollings Renton, president and CEO of Onyx Pharmaceuticals Inc., of Richmond, Calif.

ChiRex Inc., of Stamford, Conn., named Raj Iyer manager of business development.

Cohesion Technologies Inc., of Palo Alto, Calif., promoted Russell McDaniell to vice president of sales.

Connetics Corp., of Palo Alto, Calif., named to its board of directors Leon Panetta, former White House chief of staff.

FibroGen Europe Ltd., of Oulu, Finland, named Juha Keivurinta managing director.

Gene Logic Inc., of Gaithersburg, Md., appointed its chief executive officer, Michael Brennan, chairman of the board. In addition, Mark Gessler, president and chief operating officer, was appointed to the board.

Genta Inc., of Lexington, Mass., named to its board of directors Ralph Snyderman, chancellor for health affairs at Duke University.

Helicon Therapeutics Inc., of Cold Spring Harbor, N.Y., elected George Carmany chairman and CEO.

InterMune Pharmaceuticals Inc., of Burlingame, Calif., named Stephen Rosenfield senior vice president of legal affairs and general counsel, and David Cory vice president of sales and marketing. In addition, Henry Hsu is now senior director of clinical research.

Korn/Ferry International, of San Francisco, named Suzanne Zebedee a principal, where she is a member of the biotechnology and healthcare specialty practices.

Kosan Biosciences Inc., of Hayward, Calif., named Brian Metcalf senior vice president and chief scientific officer, and C. Richard Hutchinson vice president.

Matrix Pharmaceutical Inc., of Fremont, Calif., appointed Eda Cook vice president of regulatory affairs.

Metabolix Inc., of Cambridge, Mass., named James Barber president and CEO.

Oxford GlycoSciences plc, of Oxford, UK, appointed Carl Foster senior vice president, business development.

PE Corp., of Norwalk, Conn., named Thomas Livingston secretary.

RTP Pharma Inc., of Montreal, appointed J. Gregory Ford vice president of business development, and Andrea Mueller business development analyst.

Trega Biosciences Inc., of San Diego, appointed Bruce L.A. Carter, corporate executive vice president and chief scientific officer at Novo Nordisk, to its board of directors.

Triangle Pharmaceuticals Inc., of Durham, N.C., named Chris Rallis president and chief operating officer.

Trimeris Inc., of Durham, N.C., named M. Nixon Ellis executive vice president and chief business officer.

ViaMed Inc., of Fremont, Calif., named Steve Williams chief operating officer.